A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage Ⅲ lung adenocarcinoma.
Phase of Trial: Phase I
Latest Information Update: 10 Oct 2017
At a glance
- Drugs Nedaplatin (Primary) ; Pemetrexed (Primary)
- Indications Adenocarcinoma
- Focus Adverse reactions
- 10 Oct 2017 New trial record